10 employees
D-Kimia develops novel diagnostic solutions to detect a broad range of diseases by targeting the nucleic acid signature of the disease.
2013
D-Kimia Diagnostic Solutions raised undisclosed on September 30, 2013
Investors: American University in Cairo and -